VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,938,922 | +2.1% | 38,033 | 0.0% | 0.02% | +13.3% |
| Q2 2023 | $1,899,368 | +33.2% | 38,033 | 0.0% | 0.02% | +25.0% |
| Q1 2023 | $1,425,477 | -21.8% | 38,033 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $1,823,682 | +99.7% | 38,033 | 0.0% | 0.02% | +100.0% |
| Q3 2022 | $913,000 | +10.3% | 38,033 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $828,000 | -9.8% | 38,033 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $918,000 | +1.4% | 38,033 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $905,000 | -6.2% | 38,033 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $965,000 | +12.7% | 38,033 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $856,000 | +14.0% | 38,033 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $751,000 | – | 38,033 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |